As of 2025-12-22, the Relative Valuation of 89Bio Inc (ETNB) is (32.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.84 USD, the upside of 89Bio Inc based on Relative Valuation is -318.1%.
The range of the Relative Valuation is (23.22) - (43.96) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.2x - 14.5x | 9.9x |
| Forward P/E multiples | 7.7x - 15.3x | 11.5x |
| Fair Price | (23.22) - (43.96) | (32.37) |
| Upside | -256.5% - -396.2% | -318.1% |
| Date | P/E |
| 2025-10-29 | -4.89 |
| 2025-10-28 | -4.89 |
| 2025-10-27 | -4.89 |
| 2025-10-24 | -4.88 |
| 2025-10-23 | -4.88 |
| 2025-10-22 | -4.88 |
| 2025-10-21 | -4.88 |
| 2025-10-20 | -4.88 |
| 2025-10-17 | -4.87 |
| 2025-10-16 | -4.87 |
| 2025-10-15 | -4.88 |
| 2025-10-14 | -4.88 |
| 2025-10-13 | -4.88 |
| 2025-10-10 | -4.88 |
| 2025-10-09 | -4.90 |
| 2025-10-08 | -4.88 |
| 2025-10-07 | -4.89 |
| 2025-10-06 | -4.90 |
| 2025-10-03 | -4.90 |
| 2025-10-02 | -4.89 |
| 2025-10-01 | -4.85 |
| 2025-09-30 | -4.85 |
| 2025-09-29 | -4.85 |
| 2025-09-26 | -4.85 |
| 2025-09-25 | -4.85 |
| 2025-09-24 | -4.85 |
| 2025-09-23 | -4.86 |